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CASE REPORT 
FAMILIAL HOMOCYSTINURIA 
Fareena Bilwani, Nadir Ali Syed: Mohammed Usman and Mohammed Khurshid 
ABSTRACT 
Two cases of siblings diagnosed as cases of familial homocystinuria are reported. Both the cases have classical 
presentation of familial homocystinuria including history of dislocation of lens of the right eye. Brother had history of 
psychomotor retardation while sister had a significant history of deep vein-thrombosis. Levels of plasma homocysteine 
were elevated and urinary homocysteine was positive in both the cases. 
KEY WORDS: Homocysteine. Familial homocystinuria. Cystathione-B synthase. N-methyf tetrahydrofofate reductase. 
li\JTRODUCTIO\. 
In the last tvvo decades, a growing amount of interest has been 
focussed on hyperhomocystinemia as a risk factor of 
thromboembolic disease. We present cases of tvvo siblings 
diagnosed as cases of familial homocystinuria with 
characteristic clinical presentation and biochemical results.! 
This report highlights the classical presentation of this rare 
cause of thrombophilia. 
CASE RFPORT 
CASE I: An 18-year-old female presented in hematology-
oncology clinic with complains of pain and swelling in left calf 
of tvvo weeks duration. Her birth and developmental history 
was unremarkable. She was born by caesarean section without 
any complications. There was no history of delayed 
milestones. Her diet and appetite were normal. 
Her past medical history was significant with tvvo catastrophic 
events. One occurred in August 1994 with swelling and pain 
in the right calf for 24 hours. Apart from routine laboratory 
investigations done at that time, a doppler ultrasonographic 
study revealed thrombosis in deep veins of the leg. This was 
followed by amputation of the right leg. She also had history 
of subluxation of the right eye lens in August 1995 followed by 
surgical correction. 
She was a product of consanguineous marriage. Both parents 
and younger sister were healthy with no history of any 
significant medical illness. Moreover, her elder brother had 
significant medical history (described as case 2). 
At the time of presentation her general examination showed 
pallor while examination of limbs revealed swelling and 
tenderness of left calf. Rest of the systemic examination was 
unremarkable. 
Her complete blood counts at the time of presentation 
revealed anemia with hemoglobin of 8.3 gm I dl, while TLC, 
differential count and platelet counts were normal. Peripheral 
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blood film revealed anisocytosis, macrocytes, polychromasia, 
target cells, poikilocytes and occasional right shift neutrophils. 
The serum vitamin 812 levels and red cell folate levels were 
normal. Hemoglobin electrophoresis was normal. 
She was investigated for various causes of inherited 
thrombophilia. She was found to have positive urinarv 
homocysteine assay.l, while the plasma homocysteine leveb 
were elevated i.e. 117.5 p.mol/L. Other laboratory 
investigations were normal. 
Based on the clinical presentation and laboratory data, 
including normal vitamin 812 and red cell folate levels along 
with a high level of plasma homocysteine she was diagnosed 
to be a case of familial homocystinuria. She was then started 
on a trial of folic acid, vitamin-86 (pyridoxine) and vitamin Bn 
(methylcobolamin) supplementation. 
CASF ~:The brother was 21-year-old who presented to the 
neurology clinic with history of mental retardation since birth. 
He also complained of pain and swelling of superficial call 
veins since 4 months. He was born through a caesarean 
section. His diet and appetite were also normaL His younger 
sister was diagnosed to be a case of familial homocystinuria 
(described as case 1).His past medical history included an 
event of dislocation of lens of the right eye in 1987 followed by 
surgical correction. 
At the time of presentation, examination of limbs revealed 
dilated but non-tender superficial veins of right leg. CNS 
examination revealed psychomotor retardation. Rest of the 
examination was unremarkable. 
In view of his medical and family history, urinary 
homocysteine was performed and found to be positive. The 
plasma homocysteine levels were elevated i.e. 364.6 p.mol/L. 
Doppler ultrasonography of the right leg showed no evidence 
of deep vein thrombosis. His serum Br2 and red cell folate 
levels were also found to be normal. 
A diagnosis of familial homocystinuria was made and since 
then he was kept on folic acid, vitamin B6 (pyridoxine) and 
vitamin B12 (methylcobolamin) supplementation. 
In both these cases activity of cystathione- fS synthase and 
N-metl1yltetrahydrofolate reductase (MTHFR) could not be 
done for further characterization of familial homocystinuri;; 
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because of the unavailability of these tests. However, clinical 
history and high levels of plasma homocysteine were 
significant enough to make a diagnosis of familial 
homocystinuria. 
IJtSCUSS!O~ 
Homocysteine is a sulfur-containing amino acid formed 
during the metabolism of methionine. Homocysteine is 
metabolized by one of the two pathways.2 remethylation and 
transulfuration. Remethylation is catalyzed by methionine 
synthase, for which vitamin B12 is an essential cofactor. 
N-methyltetra-hydrofolate is the donor in this reaction and 
N-methyltetrahydrofolate reductase (MTHFR) act as a catalyst. 
Under conditions in which excess methionine is present, 
homocysteine enters transulfuration pathway, a reaction 
catalyzed by vitamin B, dependent enzyme cystathione-B synthase. 
Familial homocystinuria is an autosomal recessive disorder 
and a number of defects have been identified) Familial 
homocystinuria and homocystinemia has been classified into 
three major categories.:> Type 1 or classic homocystinuria is 
due to the deficiency of cystathione-B synthase - (CBS). It is 
also the most frequent cause of hyperhomocystinemia.4 In this 
type diagnosis is usually made after 3 years of age when 
sublaxation of lens occurs. Progressive mental retardation is 
common along with psychiatric and behavioral disorders. 
Affected individuals may also manifest skeletal abnormalities. 
Thromboembolic episodes involving both large and small 
vessels are common and may occur at any age. An elevation of 
homocysteine is the diagnostic finding. The homozygous form 
of this disease can be associated with plasma homocysteine 
concentration of upto 400 Jlmol /L.2 Type 2 homocystinuria is 
due to defects in methylcobalamin formation, which is a 
cofactor for the enzyme methionine synthase. These patients 
usually present with history of lethargy, poor feeding and 
developmental delay in the first few months of life. Laboratory 
studies reveal megaloblastic anemia, homocystinuria and 
hypomethioninemia.3 Type 3 homocystinuria is due to the 
deficiency of methylenetetrahydrofolate reductase. Complete 
absence of the enzyme usually causes mental retardation, 
microcephaly and spasticity. Laboratory findings reveal 
moderate homocystinemia and homocystinuria. The 
methionine concentration is low or normal. 
Homocysteine (and its dimer homocysteine) ordinarily is 
detectable only in trace amounts in plasma and urine. 
Homocysteine may not be detectable in urine until total 
plasma homocysteine levels exceed 150 ~-tmol/L. On this basis, 
by measuring urinary homocysteine occasional patients 
would be missed.S So when a strong suspicion is made of this 
rare entity plasma homocysteine should be measured despite 
negative urinary homocysteine. 
Obligate heterozygote carriers have 22% to 47% cystathione-
B- synthase activity in cultured fibroblasts or long-term 
cultured lymphocytes. Prenatal diagnosis is available for 
cystathione-£5-synthase deficiency using cultured chorionic 
Villus cells or amniotic fluid cells to measure the activity of this 
enzyme.6 Screening test for familial homocystinuria involves 
the determination of levels of methionine. Newer methods 
include direct methionine assay by tandem mass 
spectrometry? Elevation in methionine level may be minimal 
during the first 3 days of life until there is adequate protein 
intake. It may be preferable to screen for this disorder at 2 or 4 
weeks of age.B 
Various definitions have also been used to derive cut-off levels 
for hyperhomocystinemia. The classification by Kang.9 is now 
generally used, distinguishing moderate (15-30 J'mOI/L), 
intermediate (>30 to 100p:mol/L) and severe hyperhomo-
cystinemia (>100 p:mol /L) on the basis of concentration 
measured during fasting. 
Hyperhomocystinemia is now an established independent 
risk factor for the vascular thrombosis. Various investigators 
have reported a positive association between hyperhomo-
cystinemia and venous thrombosis.IO However, in cases of 
mild to moderate hyperhomocystinemia, controversy remains 
regarding the association between homocysteine and vascular 
occlusive disease. 
A number of other factors influence homocysteine 
metabolism, including several disease states and medications. 
Elevated plasma homocysteine levels are seen in patients with 
chronic renal failure, hypothyroidism, several types of 
carcinomas and drugs including methotrexate, phenytoin and 
theophylline etc. Elevated levels have also been reported in 
patients with pernicious anemia.2 
Uptil now, there is no consensus regarding the best method of 
treatment. However, vitamin supplementation with folic acid, 
pyridoxine and vitamin 812 is generally effecti\'e in reducing 
homocysteine concentration. This, in turn, may help in 
reducing the occurrence of thromboembolic event. 
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